Compare Duke Energy Corp (DUK) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Medpace Holdings Inc — how do they compare? Duke Energy Corp trades at $116.65 (market cap $91.10B), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Duke Energy Corp is far larger — about 5.4× Medpace Holdings Inc's market cap, and Duke Energy Corp pays a 3.71% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Medpace Holdings Inc for 14 Days on average.
| DUK | MEDP | |
|---|---|---|
Market Cap | $91.10B | $16.82B |
Volume | 4,199,050 | 223,093 |
Sector | Utilities | Health |
52-Week High | $133.46 | $630.19 |
52-Week Low | $113.23 | $393.42 |
Typical Hold Time | 74 Days | 14 Days |
Enterprise Value | $183.61B | $16.44B |
Dividend Yield | 3.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $116.84, up 1.16% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 15.78% net margin, and stable dividend payments. Revenue growth accelerated from $28.8B in 2022 to $32.24B in 2025, with positive cash flow trends emerging in 2026 forecasts.
DUK offers a balanced investment case with 40.6% analyst buy ratings and $134.44 consensus target, representing 15% upside. Key risks include rising Treasury yields pressuring utility stocks and elevated debt levels at 46.17% of assets. The data center expansion opportunity provides growth catalysts amid regulatory stability.
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
